Skip to main content

Table 2 Correlation between miR-320d or FoxM1 expression with clinicopathological features in 60 GCA patients

From: MicroRNA-320d regulates tumor growth and invasion by promoting FoxM1 and predicts poor outcome in gastric cardiac adenocarcinoma

CharacteristicsNo. of patientsRelative miR-320d expressionPRelative FoxM1 expressionP
Age (years)
 < 60196.458 ± 0.2720.1067.151 ± 0.3600.133
 ≥ 60416.392 ± 0.146 6.924 ± 0.553 
Male/female
 Male446.424 ± 0.2010.2257.115 ± 0.6280.151
 Female166.405 ± 0.105 6.937 ± 0.563 
The stomach diseases
 No186.438 ± 0.2160.1757.026 ± 0.6600.207
 Yes426.398 ± 0.281 6.973 ± 0.478 
Family history of cancer
 No276.419 ± 0.1360.3537.091 ± 0.5120.116
 Yes336.409 ± 0.237 6.957 ± 0.730 
Pathological grade
 Low differentiated196.607 ± 0.1160.0547.103 ± 0.6210.051
 Middle and high differentiated416.492 ± 0.135 6.811 ± 0.672 
Clinical stage
 Low grades I–II126.420 ± 0.1270.3077.020 ± 0.4730.201
 High grades III–IV486.405 ± 0.138 6.977 ± 0.337 
Lymph node metastasis
 Negative106.501 ± 0.2170.0576.863 ± 0.4450.044
 Positive506.399 ± 0.138 7.162 ± 0.706 
  1. P value < 0.05 is marked in italic, which means there is a significant difference between the two groups
  2. GCA Gastric cardia adenocarcinoma